KRENSAVAGE ASSET MANAGEMENT, LLC launched in 2008 to pursue a concentrated value-oriented approach to healthcare investing. KAM primarily focuses on pharmaceutical, medical device, and commercial-biotechnology companies and aims to take advantage of market inefficiencies by investing both long and short.